AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35220473 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 422)
Number of subjects: 841
Study 35220473 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (4 mg)
Number of subjects: 841
Study 35220473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 841
Study 32581009 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 357
Study 32581009 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin
Number of subjects: 357
Study 32581009 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 357
Study 35639646 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg twice/day) and folic acid (400 μg /day)
Number of subjects: 80
Study 35639646 — intervention group
Group type: COMPARATOR
Intervention: Inofolic (inositol + olic acid 200 μg twice/day)
Number of subjects: 80
Study 35639646 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 80
Study 32268118 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week alternate day fasting (ADF)
Number of subjects: 30
Study 32268118 — intervention group
Group type: COMPARATOR
Intervention: Long-term fasters
Number of subjects: 30
Study 32268118 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 34418398 — intervention group
Group type: EXPERIMENTAL
Intervention: Bexarotene (300 mg/m2 per day for 6 months)
Number of subjects: 52
Study 34418398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 34418398 — intervention group
Group type: EXPERIMENTAL
Intervention: Bexarotene
Number of subjects: 52
Study 36452175 — intervention group
Group type: EXPERIMENTAL
Intervention: ENTF therapy (1–100 Hz, < 1 G), 40 min active treatment 5 days/week for 8 weeks; 3 treatments accompanied by 10 min of concurrent physical/occupational therapy.
Number of subjects: 21
Study 36452175 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment, 40 min treatment 5 days/week for 8 weeks.
Number of subjects: 21
Study 36452175 — intervention group
Group type: EXPERIMENTAL
Intervention: ENTF therapy
Number of subjects: 21
Study 36452175 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 21
Study 32996128 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly Lactic‐Co‐Glycolic Acid‐Coated β‐Tricalcium Phosphate (PLGA‐β‐TCP)
Number of subjects: 45
Study 32996128 — intervention group
Group type: COMPARATOR
Intervention: Freeze‐dried bone allograft (FDBA) particles covered with a rapidly absorbable collagen dressing (RACD)
Number of subjects: 45
Study 32996128 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PLGA‐β‐TCP and FDBA+RACD)
Number of subjects: 45
Study 35441566 — intervention group
Group type: EXPERIMENTAL
Intervention: Tipping Point Program (TPP)
Number of subjects: 1275
Study 35441566 — intervention group
Group type: EXPERIMENTAL
Intervention: Tipping Point Program Plus (TPP+)
Number of subjects: 1275
Study 35441566 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1275
Study 32531816 — intervention group
Group type: EXPERIMENTAL
Intervention: Snow mushroom hand sanitizer (10% snow mushroom extract, 66.5% ethanol, 0.3% triclosan)
Number of subjects: 20
Study 32531816 — intervention group
Group type: COMPARATOR
Intervention: Placebo hand sanitizer
Number of subjects: 20
Study 36205472 — intervention group
Group type: EXPERIMENTAL
Intervention: PHM intervention (N = 97)
Number of subjects: 190
Study 36205472 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC; N = 93)
Number of subjects: 190
Study 32106807 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose meropenem (3 g q8h)
Number of subjects: 24
Study 32106807 — intervention group
Group type: COMPARATOR
Intervention: Standard dose meropenem (2 g q8h)
Number of subjects: 24
Study 33305681 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG therapy
Number of subjects: 4549
Study 33305681 — intervention group
Group type: COMPARATOR
Intervention: Radical cystectomy (RC)
Number of subjects: 4549
Study 34883088 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype 1 (hypoinflammatory)
Number of subjects: 304
Study 34883088 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype 2 (hyperinflammatory)
Number of subjects: 304
Study 34631289 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulley Release
Number of subjects: 40
Study 34631289 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulley Reconstruction
Number of subjects: 40
Study 36364809 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized vitamin D3 loading dose followed by daily 2000 IU
Number of subjects: 74
Study 36364809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 32041897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CE) intervention for 2 weeks
Number of subjects: 0
Study 32041897 — intervention group
Group type: COMPARATOR
Intervention: Non-CE control group
Number of subjects: 0
Study 32041897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CE) intervention
Number of subjects: 0
Study 36210321 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery with preoperative short-course radiotherapy
Number of subjects: 1207
Study 36210321 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1207
Study 36210321 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with complications
Number of subjects: 1207
Study 36210321 — intervention group
Group type: COMPARATOR
Intervention: Patients without complications
Number of subjects: 1207
Study 33258284 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 180
Study 33258284 — intervention group
Group type: COMPARATOR
Intervention: Positive Airway Pressure (PAP)
Number of subjects: 180
Study 33258284 — intervention group
Group type: EXPERIMENTAL
Intervention: MAD
Number of subjects: 180
Study 33258284 — intervention group
Group type: COMPARATOR
Intervention: PAP
Number of subjects: 180
Study 33258284 — intervention group
Group type: EXPERIMENTAL
Intervention: MAD and PAP
Number of subjects: 180
Study 35063245 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI)
Number of subjects: 30
Study 35063245 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic intervention
Number of subjects: 30
Study 35063245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35667073 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (PT)
Number of subjects: 0
Study 35667073 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular glucocorticoid injection
Number of subjects: 0
Study 32236353 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor (CGF)
Number of subjects: 19
Study 32236353 — intervention group
Group type: COMPARATOR
Intervention: Connective Tissue Graft (CTG) with Coronally Advanced Flap (CAF)
Number of subjects: 19
Study 34536606 — intervention group
Group type: EXPERIMENTAL
Intervention: PUI/NaOCl
Number of subjects: 48
Study 34536606 — intervention group
Group type: EXPERIMENTAL
Intervention: PUI/solvent
Number of subjects: 48
Study 34536606 — intervention group
Group type: EXPERIMENTAL
Intervention: SWEEPS®/NaOCl
Number of subjects: 48
Study 34536606 — intervention group
Group type: EXPERIMENTAL
Intervention: SWEEPS®/solvent
Number of subjects: 48
Study 32422597 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness tracker with daily step target for 6 weeks
Number of subjects: 0
Study 32422597 — intervention group
Group type: COMPARATOR
Intervention: Fitness tracker without specific step goals for 6 weeks
Number of subjects: 0
Study 32422597 — intervention group
Group type: COMPARATOR
Intervention: Control group documenting physical activity
Number of subjects: 0
Study 33959920 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid pain medication
Number of subjects: 381
Study 33959920 — intervention group
Group type: COMPARATOR
Intervention: Non-opioid pain medication
Number of subjects: 381
Study 33959920 — intervention group
Group type: COMPARATOR
Intervention: No pain medication
Number of subjects: 381
Study 33213413 — intervention group
Group type: EXPERIMENTAL
Intervention: Arts-based intervention (six one-hour, one-to-one facilitated arts sessions during haemodialysis)
Number of subjects: 24
Study 33213413 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care during haemodialysis)
Number of subjects: 24
Study 34176234 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 days/week intermittent VLCD
Number of subjects: 40
Study 34176234 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 days/week intermittent VLCD
Number of subjects: 40
Study 34176234 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34624665 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective working memory training (aWMT)
Number of subjects: 60
Study 34624665 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral working memory training (nWMT)
Number of subjects: 60
Study 34624665 — intervention group
Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 60
Study 36509948 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal traction method‐assisted STER (study group)
Number of subjects: 80
Study 36509948 — intervention group
Group type: COMPARATOR
Intervention: Conventional STER (control group)
Number of subjects: 80
Study 36509948 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 35559507 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (Fi O2 = 20.6 ± 0.3%)
Number of subjects: 21
Study 35559507 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (Fi O2 = 14.0 ± 0.2%)
Number of subjects: 21
Study 35559507 — intervention group
Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 21
Study 35559507 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 21
Study 35559507 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 21
Study 36148979 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (Group GA)
Number of subjects: 40
Study 36148979 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia with General Anesthesia (Group SGA)
Number of subjects: 40
Study 36148979 — intervention group
Group type: COMPARATOR
Intervention: Both Groups (GA and SGA)
Number of subjects: 40
Study 32762505 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple vinegar (AV) - 10 ml diluted in 200 ml drinking water with breakfast and dinner for 12 weeks
Number of subjects: 40
Study 32762505 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 40
Study 35320488 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentopexy (underwent LSG with omentopexy)
Number of subjects: 91
Study 35320488 — intervention group
Group type: COMPARATOR
Intervention: Non-omentopexy (underwent LSG only)
Number of subjects: 91
Study 32659029 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraspecific hybrid population (HEB‐25)
Number of subjects: 0
Study 32659029 — intervention group
Group type: EXPERIMENTAL
Intervention: Identified candidate gene REC8
Number of subjects: 0
Study 32659029 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild barley introgression patterns
Number of subjects: 0
Study 34503428 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids supplementation (oral, based on children's weight for three consecutive days)
Number of subjects: 60
Study 34503428 — intervention group
Group type: COMPARATOR
Intervention: Standard antibiotic treatment only
Number of subjects: 60
Study 32131885 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily use of lipid-rich emollient
Number of subjects: 625
Study 32131885 — intervention group
Group type: COMPARATOR
Intervention: No emollient (control)
Number of subjects: 625
Study 35778655 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Mindful Awareness Practices (MAPs) intervention, comprised of one in-person 60–min session and 6-week access to a digitally delivered MAPs curriculum (n = 27)
Number of subjects: 66
Study 35778655 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 39)
Number of subjects: 66
Study 32277809 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine (CFZ)
Number of subjects: 20
Study 32277809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32277809 — intervention group
Group type: COMPARATOR
Intervention: Part B controls (HIV without cryptosporidiosis)
Number of subjects: 20
Study 32800328 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive protection motivation
Number of subjects: 0
Study 32800328 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive protection motivation
Number of subjects: 0
Study 34253089 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos with medical footage and sad stories (unresolved or mourning)
Number of subjects: 1696
Study 34253089 — intervention group
Group type: COMPARATOR
Intervention: Videos with medical footage and uplifting story
Number of subjects: 1696
Study 34708705 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine + Diclofenac
Number of subjects: 100
Study 34708705 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol + Diclofenac
Number of subjects: 100
Study 32248906 — intervention group
Group type: EXPERIMENTAL
Intervention: LVOTAbiplane (direct planimetry)
Number of subjects: 134
Study 32248906 — intervention group
Group type: EXPERIMENTAL
Intervention: LVOTAbiplane
Number of subjects: 134
Study 36410494 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized TA (500 mg tid)
Number of subjects: 110
Study 36410494 — intervention group
Group type: COMPARATOR
Intervention: IV TA (500 mg tid)
Number of subjects: 110
Study 33656085 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 0
Study 35416437 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingjin Yiqi granules (QJYQ) combined with standard rehabilitation treatments (SRTs)
Number of subjects: 388
Study 35416437 — intervention group
Group type: COMPARATOR
Intervention: Control group (only received SRTs)
Number of subjects: 388
Study 34530402 — intervention group
Group type: EXPERIMENTAL
Intervention: EMFSTC (n = 15, 16-week practice)
Number of subjects: 31
Study 34530402 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 16, no practice)
Number of subjects: 31
Study 32157434 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of tramadol (2 mg/kg)
Number of subjects: 107
Study 32157434 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of ketamine (0.5 mg/kg)
Number of subjects: 107
Study 32157434 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 mL of peritonsillar saline)
Number of subjects: 107
Study 34415081 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) to the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 10
Study 34415081 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study 36436732 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance Use Skills Training and Exposure Post-Sexual Assault (STEPS) intervention
Number of subjects: 54
Study 36436732 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological momentary assessments
Number of subjects: 54
Study 36436732 — intervention group
Group type: EXPERIMENTAL
Intervention: STEPS intervention
Number of subjects: 54
Study 33422947 — intervention group
Group type: EXPERIMENTAL
Intervention: Butylphthalide
Number of subjects: 64
Study 33422947 — intervention group
Group type: COMPARATOR
Intervention: Non-butylphthalide
Number of subjects: 64
Study 35387669 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message-based intervention for 7 consecutive nights
Number of subjects: 50
Study 34518459 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg with/without dose titration (10 mg/day escalated to 23 mg)
Number of subjects: 160
Study 34518459 — intervention group
Group type: EXPERIMENTAL
Intervention: No dose titration
Number of subjects: 160
Study 34518459 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose titration
Number of subjects: 160
Study 35762420 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylseleninic acid (MSeA) at 3 ppm selenium
Number of subjects: 0
Study 35762420 — intervention group
Group type: EXPERIMENTAL
Intervention: Se-methylselenocysteine (MSeC) at 3 ppm selenium
Number of subjects: 0
Study 35762420 — intervention group
Group type: COMPARATOR
Intervention: Control diet (no selenium supplementation)
Number of subjects: 0
Study 32757324 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective retina therapy (SRT) with a wavelength of 527 nm
Number of subjects: 20
Study 32757324 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective retina therapy (SRT)
Number of subjects: 20
Study 32757324 — intervention group
Group type: COMPARATOR
Intervention: Untreated eyes
Number of subjects: 20
Study 35509694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (30-min sessions, 3 times a week for 5 weeks)
Number of subjects: 74
Study 35509694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 74
Study 35509694 — intervention group
Group type: COMPARATOR
Intervention: Control (relaxation for 30 min, 3 times a week for 5 weeks)
Number of subjects: 74
Study 33180985 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive treatment with vigabatrin
Number of subjects: 94
Study 33180985 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with vigabatrin
Number of subjects: 94
Study 34548243 — intervention group
Group type: EXPERIMENTAL
Intervention: Camelina sativa oil (CSO) providing 10 g/d ALA
Number of subjects: 79
Study 34548243 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty fish (FF) providing 4 fish meals/week
Number of subjects: 79
Study 34548243 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean fish (LF) providing 4 fish meals/week
Number of subjects: 79
Study 34548243 — intervention group
Group type: COMPARATOR
Intervention: Control diet limiting fish and ALA intake
Number of subjects: 79
Study 34841917 — intervention group
Group type: EXPERIMENTAL
Intervention: WiiNWalk intervention (modified Wii Fit activities for prosthetic rehabilitation)
Number of subjects: 71
Study 34841917 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (Big Brain Academy: Wii Degree)
Number of subjects: 71
Study 34841917 — intervention group
Group type: EXPERIMENTAL
Intervention: WiiNWalk intervention
Number of subjects: 71
Study 32350110 — intervention group
Group type: EXPERIMENTAL
Intervention: pAKT1T308
Number of subjects: 0
Study 32350110 — intervention group
Group type: EXPERIMENTAL
Intervention: pAKT1T308 + pAKT1S473
Number of subjects: 0
Study 32350110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ser‐473 phosphorylation
Number of subjects: 0
Study 36062316 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 16552
Study 36062316 — intervention group
Group type: COMPARATOR
Intervention: Fecal immunochemical test (FIT)
Number of subjects: 16552
Study 36062316 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy with withdrawal time ≥ 6 min
Number of subjects: 16552
Study 36062316 — intervention group
Group type: EXPERIMENTAL
Intervention: Antispasmodic use during colonoscopy
Number of subjects: 16552
Study 36062316 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy with insertion time > 20 min
Number of subjects: 16552
Study 32419304 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06651600 (200 mg once daily)
Number of subjects: 70
Study 32419304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 34558485 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture with psychological counseling
Number of subjects: 150
Study 34558485 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture
Number of subjects: 150
Study 34558485 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological counseling
Number of subjects: 150
Study 33234648 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1 μg/kg/hour continuous infusion starting on the day of operation until 08:00 on postoperative day 1)
Number of subjects: 700
Study 33234648 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline administered at the same rate as dexmedetomidine)
Number of subjects: 700
Study 33234648 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 700
Study 33234648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 700
Study 33148016 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/d
Number of subjects: 8179
Study 33148016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8179
Study 35392827 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP Video Program
Number of subjects: 6117
Study 35392827 — intervention group
Group type: COMPARATOR
Intervention: Usual ACP practices (Control)
Number of subjects: 6117
Study 32372663 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoscopic brushing and TBNA for lung adenocarcinoma diagnosis
Number of subjects: 276
Study 32372663 — intervention group
Group type: COMPARATOR
Intervention: Control group of benign lung diseases
Number of subjects: 276
Study 35130109 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus CNCM I-3690
Number of subjects: 92
Study 35130109 — intervention group
Group type: COMPARATOR
Intervention: Placebo (acidified milk)
Number of subjects: 92
Study 33823833 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 225
Study 33823833 — intervention group
Group type: EXPERIMENTAL
Intervention: Software-based intervention
Number of subjects: 225
Study 33823833 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 225
Study 33823833 — intervention group
Group type: EXPERIMENTAL
Intervention: Web and Software groups
Number of subjects: 225
Study 36129881 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait retraining intervention (6 weeks of training)
Number of subjects: 40
Study 34049690 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilation group
Number of subjects: 49
Study 34049690 — intervention group
Group type: COMPARATOR
Intervention: Non-dilation group
Number of subjects: 49
Study 32543677 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician notification for colorectal cancer screening (patient-specific reminders)
Number of subjects: 0